1. Home
  2. PODD vs VLTO Comparison

PODD vs VLTO Comparison

Compare PODD & VLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • VLTO
  • Stock Information
  • Founded
  • PODD 2000
  • VLTO 2023
  • Country
  • PODD United States
  • VLTO United States
  • Employees
  • PODD N/A
  • VLTO N/A
  • Industry
  • PODD Medical/Dental Instruments
  • VLTO Electrical Products
  • Sector
  • PODD Health Care
  • VLTO Industrials
  • Exchange
  • PODD Nasdaq
  • VLTO Nasdaq
  • Market Cap
  • PODD 22.1B
  • VLTO 26.0B
  • IPO Year
  • PODD 2007
  • VLTO N/A
  • Fundamental
  • Price
  • PODD $316.17
  • VLTO $99.50
  • Analyst Decision
  • PODD Strong Buy
  • VLTO Buy
  • Analyst Count
  • PODD 19
  • VLTO 7
  • Target Price
  • PODD $338.79
  • VLTO $114.00
  • AVG Volume (30 Days)
  • PODD 461.0K
  • VLTO 1.3M
  • Earning Date
  • PODD 11-06-2025
  • VLTO 10-28-2025
  • Dividend Yield
  • PODD N/A
  • VLTO 0.44%
  • EPS Growth
  • PODD N/A
  • VLTO 12.64
  • EPS
  • PODD 3.32
  • VLTO 3.65
  • Revenue
  • PODD $2,359,500,000.00
  • VLTO $5,452,000,000.00
  • Revenue This Year
  • PODD $29.27
  • VLTO $8.01
  • Revenue Next Year
  • PODD $18.30
  • VLTO $5.49
  • P/E Ratio
  • PODD $95.15
  • VLTO $27.26
  • Revenue Growth
  • PODD 26.00
  • VLTO 6.15
  • 52 Week Low
  • PODD $227.03
  • VLTO $83.87
  • 52 Week High
  • PODD $353.50
  • VLTO $110.11
  • Technical
  • Relative Strength Index (RSI)
  • PODD 45.04
  • VLTO 30.66
  • Support Level
  • PODD $320.76
  • VLTO $103.28
  • Resistance Level
  • PODD $326.81
  • VLTO $105.75
  • Average True Range (ATR)
  • PODD 7.36
  • VLTO 1.88
  • MACD
  • PODD 0.49
  • VLTO -0.14
  • Stochastic Oscillator
  • PODD 17.75
  • VLTO 36.93

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About VLTO Veralto Corp

Veralto is a diversified industrial firm organized into two segments, water quality as well as product quality and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.2 billion in revenue in 2024.

Share on Social Networks: